News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
822,789 Results
Type
Article (85172)
Company Profile (621)
Press Release (736996)
Section
Business (231675)
Career Advice (4086)
Deals (39620)
Drug Delivery (105)
Drug Development (90333)
Employer Resources (192)
FDA (17846)
Job Trends (17240)
News (394271)
Policy (39578)
Tag
Academia (2973)
Africa (1262)
Alliances (56283)
Alzheimer's disease (1233)
Approvals (17782)
Arizona (204)
Artificial intelligence (79)
Asia (48907)
Australia (8601)
Bankruptcy (392)
Best Places to Work (12185)
Biosimilars (68)
Biotechnology (433)
C2C Services and Suppliers (95129)
California (1679)
Canada (846)
Cancer (371)
Career advice (3493)
Cell therapy (118)
China (120)
Clinical research (70119)
Collaboration (121)
Colorado (71)
Connecticut (69)
COVID-19 (2740)
Cystic fibrosis (76)
Data (137)
Diabetes (73)
Diagnostics (6468)
Drug pricing (79)
Earnings (93489)
Employer resources (160)
Europe (111786)
Events (124503)
Executive appointments (95)
FDA (18021)
Florida (215)
Funding (101)
Gene therapy (88)
GLP-1 (602)
Government (4998)
Healthcare (20606)
Hotbed/Location (534624)
Illinois (297)
Indiana (147)
Infectious disease (2767)
Inflammatory bowel disease (98)
Interviews (804)
IPO (17456)
Job creations (5172)
Job search strategy (2848)
Kansas (99)
Layoffs (459)
Legal (10011)
Lung cancer (83)
Manufacturing (86)
Maryland (379)
Massachusetts (1477)
Medical device (14237)
Medtech (14240)
Mergers & acquisitions (21934)
Metabolic disorders (259)
Michigan (126)
Minnesota (222)
Neuroscience (1360)
New Jersey (507)
New York (507)
NextGen Class of 2024 (7620)
Non-profit (5048)
North Carolina (671)
Northern California (719)
Obesity (160)
Ohio (102)
Opinion (229)
Patents (63)
Pennsylvania (529)
People (63565)
Pharmaceutical (118)
Phase I (21526)
Phase II (30442)
Phase III (23005)
Pipeline (96)
Podcasts (72)
Postmarket research (3530)
Preclinical (9745)
Press Release (72)
Rare diseases (123)
Real estate (7359)
Recruiting (72)
Regulatory (25537)
Research institute (2629)
Resumes & cover letters (644)
South America (1640)
Southern California (645)
Startups (4268)
Texas (205)
United States (8127)
Vaccines (539)
Washington State (261)
Weight loss (152)
Date
Today (25)
Last 7 days (442)
Last 30 days (2207)
Last 365 days (40274)
2024 (26449)
2023 (42567)
2022 (53929)
2021 (58727)
2020 (57671)
2019 (51342)
2018 (39126)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 822,789 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Theolytics Awarded Significant £2M Transforming Cancer Therapeutics Grant from Innovate UK
September 2, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces CDX Development Update
September 2, 2024
·
3 min read
Press Releases
New pooled analysis published in The Lancet demonstrated reduced risk of combined CV death or worsening heart failure with semaglutide
September 2, 2024
·
10 min read
Press Releases
Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024
September 2, 2024
·
3 min read
Press Releases
Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis
September 2, 2024
·
10 min read
Press Releases
New Study Demonstrates that SL-NAD+ delivers NAD+ into Cells
September 2, 2024
·
4 min read
Press Releases
Innovent Annouces Multiple Clinical Study Results of Mazdutide to be Presented at the EASD 2024
September 2, 2024
·
6 min read
Press Releases
Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
September 2, 2024
·
5 min read
Press Releases
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
September 2, 2024
·
4 min read
Press Releases
Cytokinetics Presents New Data Related to the Safety and Long-Term Use of Aficamten at the European Society of Cardiology Congress 2024
September 2, 2024
·
13 min read
1 of 82,279
Next
